Innovita Biological Technology Co., Ltd. (SHA:688253)
China flag China · Delayed Price · Currency is CNY
57.41
-0.10 (-0.17%)
At close: Jun 2, 2026

SHA:688253 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
440.14567.09307.73166.46388.67479.74
Trading Asset Securities
1,4531,3821,5841,5311,11587.25
Cash & Short-Term Investments
1,8941,9491,8921,6971,503566.99
Cash Growth
-4.26%3.03%11.49%12.89%165.14%-4.92%
Accounts Receivable
8.851237.83105.17124.314.13
Other Receivables
3.131.851.951.6810.630.27
Receivables
11.9813.8539.78106.86134.954.4
Inventory
45.0257.1843.4761.5174.843.63
Other Current Assets
8.026.7722.217.224.4632.81
Total Current Assets
1,9592,0271,9981,8731,738647.83
Property, Plant & Equipment
125128.88120.21118.39130.29116.93
Long-Term Investments
85.9457.8935.6534.2614.945
Goodwill
3.643.64----
Other Intangible Assets
20.4118.326.797.027.257.49
Long-Term Deferred Tax Assets
23.9924.8422.6513.412.261.22
Long-Term Deferred Charges
7.397.9811.198.6512.027.31
Other Long-Term Assets
6.916.6918.4211.3138.312.1
Total Assets
2,2322,2752,2122,0661,943797.87
Accounts Payable
59.9279.1290.9363.5771.5621.16
Accrued Expenses
20.8526.7441.9425.3727.4420.31
Short-Term Debt
----17.62-
Current Portion of Leases
4.823.843.21.963.010.88
Current Income Taxes Payable
4.530.920.9516.344.312.64
Current Unearned Revenue
24.1483.4357.25100.66105.15.9
Other Current Liabilities
11.519.5615.947.3414.061.27
Total Current Liabilities
125.75213.6210.21215.23243.1152.15
Long-Term Leases
4.523.952.571.042.490.52
Long-Term Unearned Revenue
1.751.913.144.86.336.99
Long-Term Deferred Tax Liabilities
3.993.863.152.581.310.05
Total Liabilities
136223.32219.07223.65253.2459.7
Common Stock
136.98136.98136.46136.06136.06102.04
Additional Paid-In Capital
1,0571,0531,0361,0241,022255.67
Retained Earnings
984.82944.18874.94682.51531.15380.46
Treasury Stock
-78.01-78.01-50.01---
Comprehensive Income & Other
-4.66-4.18-3.65-1.02--
Total Common Equity
2,0962,0521,9931,8421,689738.17
Shareholders' Equity
2,0962,0521,9931,8421,689738.17
Total Liabilities & Equity
2,2322,2752,2122,0661,943797.87
Total Debt
9.347.785.77323.121.4
Net Cash (Debt)
1,8841,9421,8861,6941,480565.59
Net Cash Growth
-4.49%2.93%11.35%14.45%161.71%-3.73%
Net Cash Per Share
13.8414.2513.8312.4712.185.55
Filing Date Shares Outstanding
134.87134.87134.87136.06136.06102.04
Total Common Shares Outstanding
134.87134.87134.87136.06136.06102.04
Working Capital
1,8331,8141,7871,6571,494595.68
Book Value Per Share
15.5415.2114.7813.5412.427.23
Tangible Book Value
2,0722,0301,9871,8351,682730.68
Tangible Book Value Per Share
15.3615.0514.7313.4912.367.16
Buildings
-105.1297.9697.9694.6785.39
Machinery
-112.9298.2186.2177.1761.21
Construction In Progress
-3.682.37--0.2